Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37,154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial.
Su J, Li M, He L, Zhao D, Wan W, Liu Y, Xu J, Xu J, Liu H, Jiang L, Wu H, Zuo X, Huang C, Liu X, Li F, Zhang Z, Liu X, Dong L, Li T, Chen H, Li J, He D, Lu X, Huang A, Tao Y, Wang Y, Zhang Z, Wei W, Li X, Zeng X. Su J, et al. Among authors: li f, li t, li j, li x, li m. BioDrugs. 2020 Jun;34(3):381-393. doi: 10.1007/s40259-020-00408-z. BioDrugs. 2020. PMID: 32078145 Free PMC article. Clinical Trial.
[Clinical effect of tocilizumab on patients with severe active rheumatoid arthritis].
Xu S, Xie X, Tang M, Chen J, Tian J, Du J, Mao N, Liu Y, Li S, Song M, Gao J, Ling G, Li F. Xu S, et al. Among authors: li f, li s. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017 Oct 28;42(10):1174-1177. doi: 10.11817/j.issn.1672-7347.2017.10.008. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017. PMID: 29093249 Free article. Chinese.
Changes in Efficacy Indicators for Adalimumab Biosimilar Candidate (HS016) for the Treatment of Active Ankylosing Spondylitis at Various Time Points.
Su J, Li M, He L, Zhao D, Wan W, Liu Y, Xu J, Xu J, Liu H, Jiang L, Wu H, Zuo X, Huang C, Liu X, Li F, Zhang Z, Liu X, Dong L, Li T, Chen H, Li J, He D, Lu X, Huang A, Tao Y, Wang Y, Zhang Z, Wei W, Li X, Zeng X. Su J, et al. Among authors: li f, li t, li j, li x, li m. Front Pharmacol. 2020 Dec 7;11:606497. doi: 10.3389/fphar.2020.606497. eCollection 2020. Front Pharmacol. 2020. PMID: 33364967 Free PMC article.
Evaluation of adalimumab biosimilar candidate (HS016) in Chinese patients with active ankylosing spondylitis based on a health survey: sub-analysis of a phase 3 study.
Su J, Li M, He L, Zhao D, Wan W, Liu Y, Xu J, Xu J, Liu H, Jiang L, Wu H, Zuo X, Huang C, Liu X, Li F, Zhang Z, Liu X, Dong L, Li T, Chen H, Li J, He D, Lu X, Huang A, Tao Y, Wang Y, Zhang Z, Wei W, Li X, Zeng X. Su J, et al. Among authors: li f, li t, li j, li x, li m. Clin Rheumatol. 2022 Mar;41(3):731-739. doi: 10.1007/s10067-021-05943-w. Epub 2021 Oct 28. Clin Rheumatol. 2022. PMID: 34709497 Free PMC article. Clinical Trial.
37,154 results
You have reached the last available page of results. Please see the User Guide for more information.